Influence of 5-hydroxytryptamine and the effect of a new serotonin receptor antagonist (sarpogrelate) on detrusor smooth muscle of streptozotocin-induced diabetes mellitus in the rat

International Journal of Urology

Volumn 7, Issue 6, 2000, Pages 231-235

  Kodama, Masahito ^a   Takimoto, Yukie ^a  

^a SURUGADAI NIHON UNIVERSITY HOSPITAL   (Japan)

Author keywords

Diabetes mellitus; Sarpogrelate hydrochloride; Serotonin (5 HT); Urinary bladder

Indexed keywords

AZASETRON; POTASSIUM CHLORIDE; SARPOGRELATE; SEROTONIN; SEROTONIN 2A ANTAGONIST; SEROTONIN 2A RECEPTOR; SEROTONIN 3 ANTAGONIST; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER CONTRACTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DETRUSOR MUSCLE; DRUG EFFECT; HYPERPLASIA; MALE; MUSCLE HYPERTROPHY; MUSCLE ISOTONIC CONTRACTION; MUSCLE MASS; MUSCLE RELAXATION; MUSCLE TONE; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH; RATS; RATS, WISTAR; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN ANTAGONISTS; SUCCINATES; URINARY BLADDER; URINARY BLADDER DISEASES;

EID: 0034027954     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-2042.2000.00180.x     Document Type: Article

References (22)

1. 1 Frimodt-Møller C. Diabetic cystopathy. A review of the urodynamic and clinical features of neurogenic bladder dysfunction in diabetes mellitus. Dan. Med. Bull. 1978; 25: 49-60.
2. 2 Frimodt-Møller C. Diabetic cystopathy. I. A clinical study on the frequency of bladder dysfunction in diabetics. Dan. Med. Bull. 1976; 23: 267-94.
3. 3 Blaivas JG. The neurophysiology micturition: A clinical study of 550 patients. J. Urol. 1982; 127: 958-63.
4. 4 Kaplan SA, Te AE, Blaivas JG. Urodynamic findings in patients with diabetic cystopathy. J. Urol. 1995; 153: 342-4.
5. 5 Menendez V, Cofan F, Talbot-Wright R, Ricart MJ, Gutierrez R, Carretero P. Urodynamic evaluation in simultaneous insulin dependent diabetes mellitus and end stage renal disease. J. Urol. 1996; 155: 2001-4.
6. 6 Takimoto Y, Kodama M, Sugimoto S et al. The effect of 5-HT2 antagonist for urinary frequency symptom on diabetes mellitus patients. Jpn J. Urol. 1999; 90: 731-40.
7. 7 Creed KE, Tulloch AGS. The effect of pelvic nerve stimulation and some drugs on the urethra and bladder of the dog. Br. J. Urol. 1978; 50: 398-405.
8. 8 Cohen ML. Canine, but not rat bladder contracts to serotonin via activation of 5-HT2 receptors. J. Urol. 1990; 143: 1037-40.
9. 9 Saum WR, de Groat WC. The actions of 5-hydroxytryptamine on the urinary bladder and on vesical autonomic ganglia in the eat. J. Pharmacol. Exp. Ther. 1973; 185: 70-83.
10. 10 Longhurst PA, Belis JA, O'Donnel JP, Galie JR, Westfall DP. A study of the atropine-resistant component of the neurogenic response of the rabbit urinary bladder. Eur. J. Pharmacol. 1984; 99: 295-302.
11. 11 Callaghan SM, Creed KE. Electrical and mechanical activity of the isolated lower urinary tract of the guinea pig. Br. J. Pharmacol. 1981; 74: 353-8.
12. 12 Todd JK, Mack AJ. A study of human bladder detrusor muscle. Br. J. Urol. 1969; 41: 448-54.
13. 13 Hoyer D, Clarke DE, Fozard JR et al. International Union of Pharmacology Classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev. 1994; 46: 157-203.
14. 14 Klarskov P, Horby-Petersen J. Influence of serotonin on lower urinary tract smooth muscle in vitro. Br. J. Urol. 1986; 58: 507-13.
15. 15 Saxena PR, Heiligers J, Mylecharane EJ, Tio R. Excitatory 5-hydroxytryptamine receptors in the cat urinary bladder are of the M-and 5-HT2 type. J. Anton. Pharmacol. 1985; 5: 101-7.
16. 16 Horby-Petersen J, Schmidt PF, Meyhoff HH, Frimodt-Moller C, Mathiesen FR. The effects of a new serotonin receptor antagonist (ketanserin) on lower urinary tract function in patients with prostatism. J. Urol. 1985; 133: 1095-8.
17. 17 Maruyama K, Kinami J, Sugita Y, Sugiyama E, Tsuchihashi H, Nagatomo T. MCI-9042: High affinity for serotonergic receptors as assessed by radioligand binding assay. J. Pharmacobio-Dyn. 1991; 14: 177-81.
18. 18 Shafrir E (ed.). Lessons from Animal Diabetes, Biennial Review. Smith-Gordon, London, 1995.
19. 19 Longhurst PA, Bells JA. Abnormalities of rat bladder contractility in streptozotocin-induccd diabetes mellitus. J. Pharmacol. Exp. Ther. 1986; 238: 773-7.
20. 20 Lincoln, J. Crocket M, Haven AJ, Burnstock G. Rat bladder in the early stages of streptozotocin-induced diabetes. Adrenergic and cholinergic innervation. Diabetologia 1984; 26: 81-7.
21. 21 Tammela TLJ, Leggett RE, Levin RM, Longhurst PA. Temporal changes in micturition and bladder contractility after sucrose diuresis and streptozotocin-induced diabetes mellitus in rats. J. Urol. 1995; 153: 2014-21.
22. 22 Watanabe T, Miyagawa. I. The effect of partial cystectomy on the residual urine of a large bladder demonstrated in diabetic rats. J. Urol. 1999; 161: 1010-14.